Skip to main content
Premium Trial:

Request an Annual Quote

Ambion s Cell-to-Signal Kit, Apharmas Pharma Source s Easy-Transgater and Easy-Transgater-si, Acacia Research s CombiMatrix Unit and CustomArray, and TSG Partners Market Research Reports

Premium

Ambion said it has recently introduced the Cell-to-Signal kit, which uses a chemical lysis method to create cell lysates in less than five minutes at room temperature.

The cell lysates, said the company, can be used directly for RT-PCR and for monitoring siRNA-induced gene knockdown.


Apharmas Pharma Source said last week that it has launched the in vitro tranfection reagents Easy-Transgater and Easy-Transgater-si.

These reagents, said the company, are specifically designed for the delivery of DNA/RNA and siRNA into difficult-to-transfect cell lines as well as a broad range of mammalian cells.

The company also said that it has introduced pre-coated ready-to-transfect plates — in 96-well, 24-well, and 6-well formats — for high-throughput applications such as screening and gene silencing.


Acacia Research said this week that its CombiMatrix unit has introduced its new CustomArray human toxicology array.

The array contains over 12,000 probes to genes that were selected from the scientific literature and public databases as being relevant to toxicology, said Acacia. These genes include stress response genes, metabolism genes, genes involved in DNA damage repair, apoptosis, cell-cycle regulation, signal transduction, acute phase genes, stress response genes, growth factors, nuclear receptors, and transcription factors.


TSG Partners has announced the availability of market research reports on high-content screening, cell-based assays, and RNAi. Free, condensed samples of the reports can be downloaded at http://www.tsgpartners.com.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.